TTOO vs. PETV, NXGL, BTCY, PAVM, MBOT, MHUA, SSKN, AKLI, GCTK, and NURO
Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include PetVivo (PETV), NEXGEL (NXGL), Biotricity (BTCY), PAVmed (PAVM), Microbot Medical (MBOT), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Akili (AKLI), GlucoTrack (GCTK), and NeuroMetrix (NURO). These companies are all part of the "surgical & medical instruments" industry.
T2 Biosystems (NASDAQ:TTOO) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking and institutional ownership.
T2 Biosystems received 406 more outperform votes than PetVivo when rated by MarketBeat users.
T2 Biosystems has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500.
In the previous week, PetVivo had 1 more articles in the media than T2 Biosystems. MarketBeat recorded 3 mentions for PetVivo and 2 mentions for T2 Biosystems. PetVivo's average media sentiment score of 0.49 beat T2 Biosystems' score of 0.00 indicating that PetVivo is being referred to more favorably in the news media.
T2 Biosystems has a net margin of -696.19% compared to PetVivo's net margin of -1,016.64%. T2 Biosystems' return on equity of 0.00% beat PetVivo's return on equity.
23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 24.6% of PetVivo shares are held by institutional investors. 0.1% of T2 Biosystems shares are held by company insiders. Comparatively, 20.1% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
PetVivo has lower revenue, but higher earnings than T2 Biosystems.
Summary
PetVivo beats T2 Biosystems on 7 of the 12 factors compared between the two stocks.
Get T2 Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
T2 Biosystems Competitors List
Related Companies and Tools
